Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-14-001798
Filing Date
2014-04-15
Accepted
2014-04-15 16:50:40
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K hbmk_10k.htm 10-K 1414799
2 CURRENT FUND LOAN CONTRACT hbmk_ex1019.htm EX-10.19 139513
3 SUBSIDIARIES OF THE REGISTRANT hbmk_ex21.htm EX-21.1 4865
4 CERTIFICATION hbmk_ex311.htm EX-31.1 21725
5 CERTIFICATION hbmk_ex321.htm EX-32.1 7575
  Complete submission text file 0001477932-14-001798.txt   4751027

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hbmk-20131231.xml EX-101.INS 476608
7 XBRL TAXONOMY EXTENSION SCHEMA hbmk-20131231.xsd EX-101.SCH 45953
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hbmk-20131231_cal.xml EX-101.CAL 55976
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hbmk-20131231_def.xml EX-101.DEF 65737
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hbmk-20131231_lab.xml EX-101.LAB 254815
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hbmk-20131231_pre.xml EX-101.PRE 171960
Mailing Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864
Business Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864 65-6747-7883
Hubei Minkang Pharmaceutical Ltd. (Filer) CIK: 0001375850 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-53231 | Film No.: 14765516
SIC: 2834 Pharmaceutical Preparations